Mobia Medical plans IPO
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each. Mobia said its Vivistim System, which received premarket approval in 2021, is the only approved solution for chronic ischemic stroke survivors with moderate to... Read More →
A Second Chance to Walk: How OsseoMatrix™ Restores Mobility After Bone Tuberculosis
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Investors inject £17m into King’s College London medical spinout Hypervision Surgical
A university spinout which specialises in hyperspectral imaging to assist surgeons has clinched a £17m funding boost from investors including London-listed IP Group. Sky News understands that Hypervision Surgical, which was incubated at King’s College London, will announce on Wednesday... Read More →
Avenda Health’s Unfold AI Included in Expanded Medicare Physician Fee Schedule Across West Coast and Mountain West Regions
Unfold AI’s inclusion in physician fee schedules across Western markets helps broaden access to AI-guided prostate cancer care, enabling more precise treatment planning The 3D AI cancer mapping and clinical decision-making platform is reimbursable by Medicare in physician office settings... Read More →
Neurava Awarded $4 Million NIH Blueprint Optimizer Award to Develop SUDEP Risk Stratification Algorithm
BALTIMORE, April 23, 2026 /PRNewswire/ — Neurava Inc., an innovative medtech startup focused on advanced wearable monitoring solutions for epilepsy, today announced that it has been awarded a $4 million NIH Blueprint MedTech Optimizer award to support the development of... Read More →
Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
Led by Santé, the funding will support completion of the world’s first randomized HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company’s anesthesia-free, outpatient sonic therapy PALO ALTO, Calif., April 15, 2026 /PRNewswire/ — Sonire Therapeutics,... Read More →
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives of babies and mothers around the world. NEW YORK, April 14, 2026 /PRNewswire/ — A breakthrough in fetal brain monitoring developed at... Read More →
Sibel Health Receives FDA-Clearance for ANNE® Maternal, a Comprehensive and Fully Wireless Maternal-Fetal Monitoring Platform
CHICAGO, April 9, 2026 /PRNewswire/ — Sibel Health today announced FDA 510(k) clearance of ANNE® Maternal, the world’s first fully wireless, comprehensive maternal-fetal monitoring platform. Designed for continuous, simultaneous monitoring of maternal and fetal health, ANNE® Maternal combines advanced wearable... Read More →
FDA Clears InVera Infusion Device to Treat Chronic Venous Disease
April 8, 2026—InVera Medical announced FDA 510(k) clearance for the InVera infusion device for the minimally invasive treatment of diseased leg veins, including varicose veins. The device is now approved for use in the United States and European Union within... Read More →
Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Madorra Inc., a medical device company developing innovative solutions for menopause-related conditions, today announced the enrollment of the first patient in... Read More →